Related Experiment Video
Updated: Jun 7, 2026
06:52
Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
Wilson disease
1Department of Gastroenterology and Oncology, Deaconess Hospital Leipzig, Georg-Schwarz-Str. 49, 04177 Leipzig, Germany. dominik.huster@diako-leipzig.de
Best Practice & Research. Clinical Gastroenterology
|October 20, 2010
Summary
Wilson disease is an inherited disorder of copper metabolism caused by ATP7B gene mutations, affecting the liver and brain. Early diagnosis and treatment are crucial for managing symptoms and improving patient outcomes.
Area of Science:
- Genetics
- Hepatology
- Neurology
Background:
- Wilson disease is an inherited autosomal recessive disorder affecting copper metabolism.
- The ATP7B gene encodes a hepatic copper-transporting protein crucial for human copper balance.
- Copper accumulation in the liver and brain causes significant health issues.
Purpose of the Study:
- To summarize current knowledge on Wilson disease genetics and pathophysiology.
- To highlight the need for improved understanding of genotype-phenotype correlations for personalized therapy.
- To emphasize the importance of early diagnosis and timely intervention.
Main Methods:
- Review of existing literature on Wilson disease genetics, clinical manifestations, and treatment strategies.
- Analysis of genotype-phenotype correlations and the impact of copper toxicity.
- Discussion of diagnostic approaches including clinical, biochemical, and genetic examinations.
Main Results:
- Wilson disease presents with variable hepatic and neurological symptoms due to copper accumulation.
- Manifestations range from hepatitis and cirrhosis to neurological deficits like tremor and psychiatric disturbances.
- Genetic mutations in ATP7B are the underlying cause of the disorder.
Conclusions:
- Early recognition and prompt initiation of therapy are essential for a favorable prognosis in Wilson disease.
- Treatment options include copper chelators, zinc salts, and liver transplantation for severe cases.
- Further research into genotype-phenotype correlations is needed for individualized therapeutic strategies.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...